Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

European retrospective study of real-life haemophilia treatment.

Berntorp E, Dolan G, Hay C, Linari S, Santagostino E, Tosetto A, Castaman G, Álvarez-Román MT, Parra Lopez R, Oldenburg J, Albert T, Scholz U, Holmström M, Schved JF, Trossaërt M, Hermans C, Boban A, Ludlam C, Lethagen S.

Haemophilia. 2017 Jan;23(1):105-114. doi: 10.1111/hae.13111. Epub 2016 Oct 20.

PMID:
27761962
2.

Hepatitis C infection and outcomes in the Scottish haemophilia population.

Khan MM, Tait RC, Kerr R, Ludlam CA, Lowe GD, Murray W, Watson HG.

Haemophilia. 2013 Nov;19(6):870-5. doi: 10.1111/hae.12218. Epub 2013 Jun 20.

PMID:
23786361
3.

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis.

Lucking AJ, Gibson KR, Paterson EE, Faratian D, Ludlam CA, Boon NA, Fox KA, Newby DE.

Arterioscler Thromb Vasc Biol. 2013 May;33(5):1105-11. doi: 10.1161/ATVBAHA.112.300395. Epub 2013 Mar 7.

PMID:
23471234
4.

Guidelines for the management of hemophilia.

Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia.

Haemophilia. 2013 Jan;19(1):e1-47. doi: 10.1111/j.1365-2516.2012.02909.x. Epub 2012 Jul 6.

PMID:
22776238
5.

Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational study.

Zahra S, Anderson JA, Stirling D, Ludlam CA.

Gynecol Oncol. 2011 Oct;123(1):152-6. doi: 10.1016/j.ygyno.2011.06.039. Epub 2011 Jul 20.

PMID:
21777967
6.

Microparticles, malignancy and thrombosis.

Zahra S, Anderson JA, Stirling D, Ludlam CA.

Br J Haematol. 2011 Mar;152(6):688-700. doi: 10.1111/j.1365-2141.2010.08452.x. Epub 2011 Feb 8. Review.

PMID:
21303355
7.

EUHASS: The European Haemophilia Safety Surveillance system.

Makris M, Calizzani G, Fischer K, Gilman EA, Hay CR, Lassila R, Lambert T, Ludlam CA, Mannucci PM.

Thromb Res. 2011 Jan;127 Suppl 2:S22-5. doi: 10.1016/S0049-3848(10)70150-X.

8.

Biovigilance and pharmacovigilance for haemophilia.

Weinstein M, Makris M, Ludlam CA.

Haemophilia. 2010 Jul;16 Suppl 5:17-21. doi: 10.1111/j.1365-2516.2010.02288.x. Review. No abstract available.

PMID:
20590851
9.

Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes.

Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM.

Diabetes Care. 2010 Jul;33(7):1591-7. doi: 10.2337/dc10-0013.

10.

Guideline for investigation and management of adults and children presenting with a thrombocytosis.

Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, Erber W, Everington T, Green AR, Hall GW, Hunt BJ, Ludlam CA, Murrin R, Nelson-Piercy C, Radia DH, Reilly JT, Van der Walt J, Wilkins B, McMullin MF; British Committee for Standards in Haematology.

Br J Haematol. 2010 May;149(3):352-75. doi: 10.1111/j.1365-2141.2010.08122.x. Epub 2010 Mar 15. Review. No abstract available.

PMID:
20331456
11.

Vascular dysfunction in chronic obstructive pulmonary disease.

Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam CA, Drost EM, Newby DE, Macnee W.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):513-20. doi: 10.1164/rccm.200903-0414OC. Epub 2009 Jun 19.

PMID:
19542477
12.

Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention.

Mills NL, Tura O, Padfield GJ, Millar C, Lang NN, Stirling D, Ludlam C, Turner ML, Barclay GR, Newby DE.

Heart. 2009 Dec;95(24):2003-8. doi: 10.1136/hrt.2008.163162. Epub 2009 May 28.

PMID:
19482845
13.

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.

Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, Dolan G, Ingerslev J.

Haemophilia. 2009 Mar;15(2):501-8. doi: 10.1111/j.1365-2516.2008.01952.x. Epub 2009 Feb 1.

PMID:
19187194
14.

European curriculum for thrombosis and haemostasis.

Astermark J, Negrier C, Hermans C, Holme PA, Klamroth R, Kotsi P, de Moerloose P, Pasi J, Rocino A, von Depka M, Windyga J, Ludlam CA; Interdisciplinary Working Group IDWG.

Haemophilia. 2009 Jan;15(1):337-44. doi: 10.1111/j.1365-2516.2008.01836.x. No abstract available.

PMID:
19149857
15.

Vascular B1 kinin receptors in patients with congestive heart failure.

Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, Newby DE.

J Cardiovasc Pharmacol. 2008 Nov;52(5):438-44. doi: 10.1097/FJC.0b013e31818c66cb.

PMID:
19033823
16.

Acute endothelial tissue plasminogen activator release in pregnancy.

Robb AO, Mills NL, Din JN, Cameron S, Ludlam CA, Newby DE, Denison FC.

J Thromb Haemost. 2009 Jan;7(1):138-42. doi: 10.1111/j.1538-7836.2008.03207.x. Epub 2008 Oct 28.

17.

An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.

Turner ML, Ludlam CA.

Br J Haematol. 2009 Jan;144(1):14-23. doi: 10.1111/j.1365-2141.2008.07376.x. Epub 2008 Oct 17. Review.

PMID:
18950452
18.

Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose.

Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN.

Clin Toxicol (Phila). 2008 Sep;46(8):697-702. doi: 10.1080/15563650802245497.

PMID:
18803085
19.

Less severe bleeding in hemophilia B than in hemophilia A.

Lowe GD, Ludlam CA.

J Thromb Haemost. 2008 Nov;6(11):1982-3. doi: 10.1111/j.1538-7836.2008.03126.x. Epub 2008 Aug 22. No abstract available.

20.

Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.

Lang NN, Gudmundsdóttir IJ, Boon NA, Ludlam CA, Fox KA, Newby DE.

J Am Coll Cardiol. 2008 Jul 1;52(1):33-9. doi: 10.1016/j.jacc.2008.04.003.

21.

Linking the world with training and research for improving haemophilia care.

Srivastava A, Hoots WK, Soucie JM, Ludlam CA.

Haemophilia. 2008 Jul;14 Suppl 3:43-8. doi: 10.1111/j.1365-2516.2008.01712.x. No abstract available.

PMID:
18510521
22.

Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.

Gudmundsdóttir IJ, Lang NN, Boon NA, Ludlam CA, Webb DJ, Fox KA, Newby DE.

J Am Coll Cardiol. 2008 May 6;51(18):1749-56. doi: 10.1016/j.jacc.2007.12.047.

23.

Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.

Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.

Thromb Res. 2008;121(5):675-80. Epub 2007 Sep 17.

PMID:
17870147
24.

Accuracy in ECG lead placement among technicians, nurses, general physicians and cardiologists.

Rajaganeshan R, Ludlam CL, Francis DP, Parasramka SV, Sutton R.

Int J Clin Pract. 2008 Jan;62(1):65-70. Epub 2007 Aug 31.

PMID:
17764456
25.

Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease.

Robinson SD, Ludlam CA, Boon NA, Newby DE.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1651-6. Epub 2007 Apr 26.

PMID:
17463331
26.

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

Darby SC, Kan SW, Spooner RJ, Giangrande PL, Hill FG, Hay CR, Lee CA, Ludlam CA, Williams M.

Blood. 2007 Aug 1;110(3):815-25. Epub 2007 Apr 19.

27.

Plasma microparticles and vascular disorders.

Lynch SF, Ludlam CA.

Br J Haematol. 2007 Apr;137(1):36-48. Review.

PMID:
17359370
28.

Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.

Gudmundsdóttir IJ, Megson IL, Kell JS, Ludlam CA, Fox KA, Webb DJ, Newby DE.

Circulation. 2006 Oct 10;114(15):1625-32. Epub 2006 Oct 2.

PMID:
17015787
29.

Proposal to establish a European Association for Hemophilia and Allied Disorders.

Ludlam CA, Mannucci PM; Interdisciplinary Working Group.

J Thromb Haemost. 2006 Oct;4(10):2270-1. Epub 2006 Jul 21. No abstract available.

30.

Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease.

Robinson SD, Ludlam CA, Boon NA, Newby DE.

J Thromb Haemost. 2006 Oct;4(10):2262-9. Epub 2006 Jul 12.

31.

Clinical perspectives of emerging pathogens in bleeding disorders.

Ludlam CA, Powderly WG, Bozzette S, Diamond M, Koerper MA, Kulkarni R, Ritchie B, Siegel J, Simmonds P, Stanley S, Tapper ML, von Depka M.

Lancet. 2006 Jan 21;367(9506):252-61. Review.

PMID:
16427495
32.

Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.

Ludlam CA, Turner ML.

Br J Haematol. 2006 Jan;132(1):13-24. Review.

PMID:
16371015
33.

Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.

Robinson SD, Dawson P, Ludlam CA, Boon NA, Newby DE.

Clin Sci (Lond). 2006 Mar;110(3):353-60.

PMID:
16309383
34.

Management of acquired von Willebrand's syndrome in a patient requiring major surgery.

Maddox JM, Anderson JA, Plews D, Ludlam CA.

Haemophilia. 2005 Nov;11(6):633-7.

PMID:
16236115
35.
36.

Inhibition of thrombin activatable fibrinolysis inhibitor augments fibrinolysis in human whole blood.

Cruden NL, Lawes L, Masson P, Robinson SD, Ludlam CA, Newby DE.

J Thromb Haemost. 2005 Oct;3(10):2351-3. No abstract available.

37.

Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group.

Ludlam CA, Mannucci PM, Powderly WG; European Interdisciplinary Working Group.

Haemophilia. 2005 Sep;11(5):433-7.

PMID:
16128884
38.

Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.

Cruden NL, Graham C, Harding SA, Ludlam CA, Fox KA, Newby DE.

Thromb Res. 2006;118(2):189-97. Epub 2005 Aug 1.

PMID:
16055173
39.

Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease.

Robinson SD, Ludlam CA, Boon NA, Newby DE.

Heart. 2006 Feb;92(2):170-6. Epub 2005 Apr 29.

40.

A framework for genetic service provision for haemophilia and other inherited bleeding disorders.

Ludlam CA, Pasi KJ, Bolton-Maggs P, Collins PW, Cumming AM, Dolan G, Fryer A, Harrington C, Hill FG, Peake IR, Perry DJ, Skirton H, Smith M; UK Haemophilia Centre Doctors' Organisation.

Haemophilia. 2005 Mar;11(2):145-63.

PMID:
15810917
41.

The procoagulant potential of environmental particles (PM10).

Gilmour PS, Morrison ER, Vickers MA, Ford I, Ludlam CA, Greaves M, Donaldson K, MacNee W.

Occup Environ Med. 2005 Mar;62(3):164-71.

42.

B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.

Cruden NL, Tse GH, Fox KA, Ludlam CA, Megson I, Newby DE.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):772-7. Epub 2005 Jan 27.

PMID:
15681300
43.

Coagulopathy and hyperfibrinolysis in ruptured abdominal aortic aneurysm repair.

Adam DJ, Haggart PC, Ludlam CA, Bradbury AW.

Ann Vasc Surg. 2004 Sep;18(5):572-7. Epub 2004 Aug 6.

PMID:
15534737
44.

Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.

Cruden NL, Fox KA, Ludlam CA, Johnston NR, Newby DE.

Hypertension. 2004 Dec;44(6):913-8. Epub 2004 Oct 18.

PMID:
15492133
45.

Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.

Chia S, Wilson R, Ludlam CA, Webb DJ, Flapan AD, Newby DE.

Clin Sci (Lond). 2005 Jan;108(1):65-72.

PMID:
15367100
46.

Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.

Hillis GS, Pearson CV, Harding SA, Sutherland S, Ludlam CA, Marioni JC, Prescott RJ, Fox KA, Flapan AD.

Am Heart J. 2004 Jul;148(1):72-9.

PMID:
15215794
47.

Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis.

Chia S, Megson IL, Ludlam CA, Fox KA, Newby DE.

Thromb Res. 2003;111(6):343-9.

PMID:
14698651
48.

von Willebrand factor and platelet count in ruptured abdominal aortic aneurysm repair.

Adam DJ, Haggart PC, Ludlam CA, Bradbury AW.

Eur J Vasc Endovasc Surg. 2003 Oct;26(4):412-7.

49.

Effects of acute liver injury on blood coagulation.

Kerr R, Newsome P, Germain L, Thomson E, Dawson P, Stirling D, Ludlam CA.

J Thromb Haemost. 2003 Apr;1(4):754-9.

50.

Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.

Witherow FN, Dawson P, Ludlam CA, Webb DJ, Fox KA, Newby DE.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1667-70. Epub 2003 Jul 17.

PMID:
12869356

Supplemental Content

Loading ...
Support Center